Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 1
2006 3
2007 2
2008 4
2009 3
2010 3
2011 2
2012 3
2013 5
2014 1
2015 5
2016 2
2017 4
2018 4
2019 4
2020 5
2021 6
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Dendrimer-nanoparticle conjugates in nanomedicine.
Parat A, Bordeianu C, Dib H, Garofalo A, Walter A, Bégin-Colin S, Felder-Flesch D. Parat A, et al. Among authors: garofalo a. Nanomedicine (Lond). 2015;10(6):977-92. doi: 10.2217/nnm.14.196. Nanomedicine (Lond). 2015. PMID: 25867861 Review.
Histopathological changes of organ dysfunction in sepsis.
Garofalo AM, Lorente-Ros M, Goncalvez G, Carriedo D, Ballén-Barragán A, Villar-Fernández A, Peñuelas Ó, Herrero R, Granados-Carreño R, Lorente JA. Garofalo AM, et al. Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):45. doi: 10.1186/s40635-019-0236-3. Intensive Care Med Exp. 2019. PMID: 31346833 Free PMC article. Review.
Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents.
Occhiuzzi MA, Lico G, Ioele G, De Luca M, Garofalo A, Grande F. Occhiuzzi MA, et al. Among authors: garofalo a. Eur J Med Chem. 2023 Jan 15;246:114971. doi: 10.1016/j.ejmech.2022.114971. Epub 2022 Nov 28. Eur J Med Chem. 2023. PMID: 36462440 Review.
Small molecule inhibitors of CXCR4.
Debnath B, Xu S, Grande F, Garofalo A, Neamati N. Debnath B, et al. Among authors: garofalo a. Theranostics. 2013;3(1):47-75. doi: 10.7150/thno.5376. Epub 2013 Jan 15. Theranostics. 2013. PMID: 23382786 Free PMC article. Review.
Computational Approaches for the Discovery of GPER Targeting Compounds.
Grande F, Occhiuzzi MA, Lappano R, Cirillo F, Guzzi R, Garofalo A, Jacquot Y, Maggiolini M, Rizzuti B. Grande F, et al. Among authors: garofalo a. Front Endocrinol (Lausanne). 2020 Aug 4;11:517. doi: 10.3389/fendo.2020.00517. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32849301 Free PMC article. Review.
CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy.
Grande F, Occhiuzzi MA, Rizzuti B, Ioele G, De Luca M, Tucci P, Svicher V, Aquaro S, Garofalo A. Grande F, et al. Among authors: garofalo a. Molecules. 2019 Feb 2;24(3):550. doi: 10.3390/molecules24030550. Molecules. 2019. PMID: 30717348 Free PMC article. Review.
Small molecules anti-HIV therapeutics targeting CXCR4.
Grande F, Garofalo A, Neamati N. Grande F, et al. Among authors: garofalo a. Curr Pharm Des. 2008;14(4):385-404. doi: 10.2174/138161208783497714. Curr Pharm Des. 2008. PMID: 18289065 Review.
67 results